Venmax Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 15-07-2024
- Paid Up Capital ₹ 5.24 Cr
as on 15-07-2024
- Company Age 36 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 6.50 Cr
as on 15-07-2024
- Revenue -20.42%
(FY 2016)
- Profit -72.51%
(FY 2016)
- Ebitda -20.43%
(FY 2016)
- Net Worth -40.95%
(FY 2016)
- Total Assets -29.55%
(FY 2016)
About Venmax Drugs And Pharmaceuticals
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 531015.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 5.24 Cr.
The company has closed loans amounting to ₹6.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Venmax Drugs And Pharmaceuticals Limited India is Ram Alladi as CFO. Ramakrishnaiah Appanaboyana, Nooka Krishnaiah, and Raj Rai serve as directors at the Company.
- CIN/LLPIN
L24230TG1988PLC009102
- Company No.
009102
- Stock Symbol
BSE : 531015
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
28 Sep 1988
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Listed
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Venmax Drugs And Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Alladi  | CFO | 14-Nov-2018 | Current |
| Raj Rai | Managing Director | 09-May-2018 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramakrishnaiah Appanaboyana | Director | 31-Dec-2005 | Current |
| Nooka Krishnaiah | Director | 03-Sep-2015 | Current |
Financial Performance and Corporate Structure Insights of Venmax Drugs And Pharmaceuticals.
Venmax Drugs And Pharmaceuticals Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 20.42% decrease. The company also saw a substantial fall in profitability, with a 72.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Venmax Drugs And Pharmaceuticals?
In 2017, Venmax Drugs And Pharmaceuticals had a promoter holding of 23.13% and a public holding of 76.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ananya Rai Paper And Allied Products Private LimitedActive 6 years 7 monthsRaj Rai is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 11 Jul 2008 | ₹1.50 Cr | Satisfied |
A.P. State Financial Corporation Creation Date: 17 Aug 1999 | ₹1.43 Cr | Satisfied |
A.P. Industrial Development Corporation Ltd. Creation Date: 02 Aug 1999 | ₹7.00 M | Satisfied |
How Many Employees Work at Venmax Drugs And Pharmaceuticals?
Venmax Drugs And Pharmaceuticals has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Venmax Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venmax Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
